Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma

Cancer Letters

Volumn 208, Issue 1, 2004, Pages 43-49

  Sako, Akihiro ^a   Kitayama, Joji ^a   Kaisaki, Shoichi ^a   Nagawa, Hirokazu ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hyperlipidemia; Lymphatic metastasis; Superficial esophageal cancer

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; SUPERFICIAL CANCER; TRIACYLGLYCEROL BLOOD LEVEL;

CARCINOMA, SQUAMOUS CELL; CHOLESTEROL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; HYPERLIPIDEMIAS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 16544386314     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.11.010     Document Type: Article

References (51)

1. Akiyama H., Tsurumaru M., Kawamura T., Ono Y. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann. Surg. 194:1981;438-446.
2. Osugi H., Takemura M., Takada N., Hirohashi K., Kinoshita H., Higashino M. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br. J. Surg. 89:2002;909-913.
3. Eloubeidi M.A., Desmond R., Arguedas M.R., Reed C.E., Wilcox C.M. Prognostic factors for the survival of patients with esophageal carcinoma in the US: the importance of tumor length and lymph node status. Cancer. 95:2002;1434-1443.
4. Endo M., Kawano T. Detection and classification of early squamous cell esophageal cancer. Dis. Esophagus. 10:1997;155-158.
5. Fujita H., Sueyoshi S., Yamana H., Shinozaki K., Toh U., Tanaka Y., et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J. Surg. 25:2001;424-431.
6. Tachibana M., Yoshimura H., Kinugasa S., Hashimoto N., Dhar D.K., Abe S., et al. Clinicopathological features of superficial squamous cell carcinoma of the esophagus. Am. J. Surg. 174:1997;49-53.
7. Conio M., Gostout C.J. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma. Analysis of 240 surgically resected tumors. Gastrointest Endosc. 54:2001;668-669.
8. Watanabe M., Kuwano H., Araki K., Kawaguchi H., Saeki H., Kitamura K., et al. Prognostic factors in patients with submucosal carcinoma of the oesophagus. Br. J. Cancer. 83:2000;609-613.
9. Hiatt R.A., Friedman G.D., Bawol R.D., Ury H.K. Breast cancer and serum cholesterol. J. Natl Cancer Inst. 68:1982;885-889.
10. Gaziano J.M., Hennekens C.H. Dietary fat and risk of prostate cancer. J. Natl Cancer Inst. 87:1995;1427-1428.
11. Howe G.R., Aronson K.J., Benito E., Castelleto R., Cornee J., Duffy S., et al. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control. 8:1997;215-228.
12. Sherwin R.W., Wentworth D.N., Cutler J.A., Hulley S.B., Kuller L.H., Stamler J. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. J. Am. Med. Assoc. 257:1987;943-948.
13. Henriksson P., Eriksson M., Ericsson S., Rudling M., Stege R., Berglund L., Angelin B. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet. 2:1989;1178-1180.
14. Nomura A.M., Stemmermann G.N., Chyou P.H. Prospective study of serum cholesterol levels and large-bowel cancer. J. Natl Cancer Inst. 83:1991;1403-1407.
15. The Japanese Society for Esophageal Disease. Japanese Society for Esophageal Disease. 2001.
16. Ikeda Y., Ozawa S., Ando N., Kitagawa Y., Ueda M., Kitajima M. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann. Thorac. Surg. 62:1996;835-838.
17. Kawamura T., Goseki N., Koike M., Takizawa T., Endo M. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings. Cancer. 77:1996;843-849.
18. Chino O., Makuuchi H., Shimada H., Machimura T., Mitomi T., Osamura R.Y. Assessment of the proliferative activity of superficial esophageal carcinoma using MIB-1 immunostaining for the Ki-67 antigen. J. Surg. Oncol. 67:1998;18-24.
19. Nakajima Y., Nagai K., Miyake S., Ohashi K., Kawano T., Iwai T. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn. J. Cancer Res. 93:2002;305-312.
20. Matsumoto M., Natsugoe S., Nakashima S., Okumura H., Sakita H., Baba M., et al. Clinical significance and prognostic value of apoptosis related proteins in superficial esophageal squamous cell carcinoma. Ann. Surg. Oncol. 8:2001;598-604.
21. Yamamoto H., Itoh F., Iku S., Hosokawa M., Imai K. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin. Cancer Res. 7:2001;896-900.
22. Yamamoto H., Iku S., Itoh F., Tang X., Hosokawa M., Imai K. Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer. 91:2001;1324-1331.
23. Kitayama H.K.J., Kaisaki S., Suzuki H., Fujii S., Nagawa H. Hyperlipidemia is positively correlated with lymphatic metastasis in early gastric cancers in men. Br. J. Surg. 2003;. in press.
24. Gal D., MacDonald P.C., Porter J.C., Simpson E.R. Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int. J. Cancer. 28:1981;315-319.
25. Vitols S., Norgren S., Juliusson G., Tatidis L., Luthman H. Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells. Blood. 84:1994;2689-2698.
26. Sumi S., Beauchamp R.D., Townsend C.M. Jr., Uchida T., Murakami M., Rajaraman S., et al. Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology. 103:1992;982-989.
27. Feleszko W., Jakobisiak M. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin. Cancer Res. 6:2000;1198-1199.
28. Dimitroulakos J., Ye L.Y., Benzaquen M., Moore M.J., Kamel-Reid S., Freedman M.H., et al. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Clin. Cancer Res. 7:2001;158-167.
29. Kort W.J., Hulsmann W.C., Stehman T.E. Modulation of metastatic ability by inhibition of cholesterol synthesis. Clin. Exp. Metastasis. 7:1989;517-523.
30. Jani J.P., Specht S., Stemmler N., Blanock K., Singh S.V., Gupta V., Katoh A. Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis. Invasion Metastasis. 13:1993;314-324.
31. Hawk M.A., Cesen K.T., Siglin J.C., Stoner G.D., Ruch R.J. Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin. Cancer Lett. 109:1996;217-222.
32. Agarwal B., Rao C.V., Bhendwal S., Ramey W.R., Shirin H., Reddy B.S., Holt P.R. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology. 117:1999;838-847.
33. Kusama T., Mukai M., Iwasaki T., Tatsuta M., Matsumoto Y., Akedo H., et al. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology. 122:2002;308-317.
34. Bigler R.D., Khoo M., Lund-Katz S., Scerbo L., Esfahani M. Identification of low-density lipoprotein as a regulator of Fc receptor-mediated phagocytosis. Proc. Natl Acad. Sci. USA. 87:1990;4981-4985.
35. Esfahani M., Bigler R.D., Alfieri J.L., Lund-Katz S., Baum J.D., Scerbo L. Cholesterol regulates the cell surface expression of glycophospholipid- anchored CD14 antigen on human monocytes. Biochim. Biophys. Acta. 1149:1993;217-223.
36. Stewart-Phillips J.L., Lough J., Phillips N.C. The effect of a high-fat diet on murine macrophage activity. Int. J. Immunopharmacol. 13:1991;325-332.
37. McCarthy B.M., Okano Y., Nakayasu T., Macy M., Watson S.R., Harmony J.A. Plasma lipoproteins and transferrin regulate the proliferation of a continuous T lymphocyte cell line. J. Lipid Res. 28:1987;1067-1077.
38. Kwak B., Mulhaupt F., Myit S., Mach F. Statins as a newly recognized type of immunomodulator. Nat. Med. 6:2000;1399-1402.
39. Munford R.S. Statins and the acute-phase response. N. Engl. J. Med. 344:2001;2016-2018.
40. Thun M.J., Namboodiri M.M., Heath C.W. Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 325:1991;1593-1596.
41. Holland J.A., Pritchard K.A., Rogers N.J., Stemerman M.B. Perturbation of cultured human endothelial cells by atherogenic levels of low-density lipoprotein. Am. J. Pathol. 132:1988;474-478.
42. Redl H., Schlag G., Kneidinger R., Ohlinger W., Davies J. Response of the endothelium to trauma and sepsis. Adherence, cytokine effects and procoagulatory response. Arzneimittelforschung. 44:1994;443-446.
43. van der Wal A.C., Das P.K., Tigges A.J., Becker A.E. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am. J. Pathol. 141:1992;1427-1433.
44. Yuan Y., Verna L.K., Wang N.P., Liao H.L., Ma K.S., Wang Y., et al. Cholesterol enrichment upregulates intercellular adhesion molecule-1 in human vascular endothelial cells. Biochim. Biophys. Acta. 1534:2001;139-148.
45. Haller H., Schaper D., Ziegler W., Philipp S., Kuhlmann M., Distler A., Luft F.C. Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension. 25:1995;511-516.
46. Gebuhrer V., Murphy J.F., Bordet J.C., Reck M.P., McGregor J.L. Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem. J. 306:(Pt 1):1995;293-298.
47. Mehta N., Hordines J., Sykes D., Doerr R.J., Cohen S.A. Low-density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro. Clin. Exp. Metastasis. 16:1998;587-594.
48. Rader D.J., Jaye M. Endothelial lipase: a new member of the triglyceride lipase gene family. Curr. Opin. Lipidol. 11:2000;141-147.
49. Hennig B., Toborek M., McClain C.J. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J. Am. Coll. Nutr. 20:2001;97-105.
50. Erickson J.R., Hasegawa Y., Fang X., Eder A., Mao M., Furui T., et al. Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management. Prostaglandins. 64:2001;63-81.
51. Huang M.C., Graeler M., Shankar G., Spencer J., Goetzl E.J. Lysophospholipid mediators of immunity and neoplasia. Biochim. Biophys. Acta. 1582:2002;161-167.